<table border="1"><tr><th>Name UICPA</th><td><ul><li>5-carbamoyl-5 | H | -dibenzo( | b |, | f | )azepine</li></ul></td></tr><tr><th>N | o | CAS</th><td><ul><li>298-46-4 | 85756-57-6 | (dihydrate)</li></ul></td></tr><tr><th>N | o | ECHA</th><td><ul><li>100.005.512</li></ul></td></tr><tr><th>ATC Code</th><td><ul><li>N03 | AF01</li></ul></td></tr><tr><th>DrugBank</th><td><ul><li>APRD00337</li></ul></td></tr><tr><th>PubChem</th><td><ul><li>2554</li></ul></td></tr><tr><th>Formula</th><td><ul><li>C | 15 | H | 12 | N | 2 | O | [Isomeres]</li></ul></td></tr><tr><th>Molar mass</th><td><ul><li>236.2686 ± 0.0135 g/mol | C 76.25%, H 5.12%, N 11.86 %, O 6.77%,</li></ul></td></tr><tr><th>Bioavailability</th><td><ul><li>80%</li></ul></td></tr><tr><th>Protein binding</th><td><ul><li>76%</li></ul></td></tr><tr><th>Metabolism</th><td><ul><li>Hepatic by CYP3A4 (in 10.11-epoxycarbamazepine)</li></ul></td></tr><tr><th>Half-life of | elim.</th><td><ul><li>25–65 hours</li></ul></td></tr><tr><th>Excretion</th><td><ul><li>2–3% unchanged excretion in urine</li></ul></td></tr><tr><th>Route of administration</th><td><ul><li>oral</li></ul></td></tr></table>